Ruconest

conestat alfa · Pharming Technologies B.V.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Ruconest, covering 2012-02-17 to 2025-12-19. Get the full timeline:

Most recent: EMA Authorised: Ruconest (recombinant human C1-inhibitor) — Pharming Group N.V.